Intrinsic Value of S&P & Nasdaq Contact Us

VectivBio Holding AG VECT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • CH • USD

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+6.7%

Financial Health Score — VECT

VectivBio Holding AG (VECT) has an overall financial health rating of B with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2023-07-07.

B
Overall Rating
2023-07-07

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2023-07-07 B -/5 -/5 -/5 -/5 -/5 -/5
2023-07-06 B -/5 -/5 -/5 -/5 -/5 -/5
2023-07-05 B -/5 -/5 -/5 -/5 -/5 -/5
2023-07-03 B -/5 -/5 -/5 -/5 -/5 -/5
2023-06-30 B -/5 -/5 -/5 -/5 -/5 -/5
2023-06-29 B -/5 -/5 -/5 -/5 -/5 -/5
2023-06-28 B -/5 -/5 -/5 -/5 -/5 -/5
2023-06-27 B -/5 -/5 -/5 -/5 -/5 -/5
2023-06-26 B -/5 -/5 -/5 -/5 -/5 -/5
2023-06-23 B -/5 -/5 -/5 -/5 -/5 -/5
2023-06-22 B -/5 -/5 -/5 -/5 -/5 -/5
2023-06-21 B -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message